UroGen Pharma Ltd. Earnings Per Share (Basic)
UroGen Pharma Ltd. (URGN) reported Earnings Per Share (Basic) of -$0.28 per share for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:EarningsPerShareBasic · last filed 2026-08-05
- UroGen Pharma Ltd. earnings per share, basic for the quarter ending 2026-06-30 was -$0.28.
- UroGen Pharma Ltd. earnings per share, basic for the quarter ending 2026-03-31 was -$0.47.
- UroGen Pharma Ltd. earnings per share, basic for the quarter ending 2025-09-30 was -$0.69.
- UroGen Pharma Ltd. earnings per share, basic for the quarter ending 2025-06-30 was -$1.05.
- UroGen Pharma Ltd. earnings per share, basic for fiscal 2025 was -$3.19.
- UroGen Pharma Ltd. earnings per share, basic for fiscal 2024 was -$2.96.
- UroGen Pharma Ltd. earnings per share, basic for fiscal 2023 was -$3.55.
- UroGen Pharma Ltd. earnings per share, basic for fiscal 2022 was -$4.81.
| Period end | Earnings Per Share, Basic 3 month | Earnings Per Share, Basic 3 month as first filed | Earnings Per Share, Basic 6 month | Earnings Per Share, Basic 6 month as first filed | Earnings Per Share, Basic 9 month | Earnings Per Share, Basic 9 month as first filed | Earnings Per Share, Basic 12 month |
|---|---|---|---|---|---|---|---|
| 2026-06-30 | -$0.28 10-Q · filed 2026-08-05 | -$0.75 10-Q · filed 2026-08-05 | |||||
| 2026-03-31 | -$0.47 10-Q · filed 2026-05-06 | ||||||
| 2025-12-31 | -$3.19 10-K · filed 2026-03-02 | ||||||
| 2025-09-30 | -$0.69 10-Q · filed 2025-11-06 | -$2.66 10-Q · filed 2025-11-06 | |||||
| 2025-06-30 | -$1.05 10-Q · filed 2026-08-05 | -$1.97 10-Q · filed 2026-08-05 | |||||
| 2025-03-31 | -$0.92 10-Q · filed 2026-05-06 | ||||||
| 2024-12-31 | -$0.80 10-K · filed 2025-03-10 | -$2.96 10-K · filed 2026-03-02 | |||||
| 2024-09-30 | -$0.51 10-Q · filed 2025-11-06 | -$0.55 10-Q · filed 2024-11-06 | -$2.15 10-Q · filed 2025-11-06 | -$2.36 10-Q · filed 2024-11-06 | |||
| 2024-06-30 | -$0.82 10-Q · filed 2025-08-07 | -$0.91 10-Q · filed 2024-08-13 | -$1.69 10-Q · filed 2025-08-07 | -$1.87 10-Q · filed 2024-08-13 | |||
| 2024-03-31 | -$0.87 10-Q · filed 2025-05-12 | -$0.97 10-Q · filed 2024-05-13 | |||||
| 2023-12-31 | -$0.72 10-K · filed 2025-03-10 | -$3.55 10-K · filed 2025-03-10 | |||||
| 2023-09-30 | -$0.68 10-K · filed 2025-03-10 | -$2.89 10-K · filed 2025-03-10 | |||||
| 2023-06-30 | -$1.03 10-K · filed 2025-03-10 | -$2.33 10-K · filed 2025-03-10 | |||||
| 2023-03-31 | -$1.30 10-K · filed 2025-03-10 | ||||||
| 2022-12-31 | -$4.81 10-K · filed 2024-03-14 | ||||||
| 2022-09-30 | -$1.13 10-Q · filed 2023-11-14 | -$3.56 10-Q · filed 2023-11-14 | |||||
| 2022-06-30 | -$1.18 10-Q · filed 2023-08-10 | -$2.43 10-Q · filed 2023-08-10 | |||||
| 2022-03-31 | -$1.25 10-Q · filed 2023-05-11 | ||||||
| 2021-12-31 | -$4.96 10-K · filed 2023-03-24 | ||||||
| 2021-09-30 | -$1.35 10-Q · filed 2022-11-10 | -$3.69 10-Q · filed 2022-11-10 | |||||
| 2021-06-30 | -$1.17 10-Q · filed 2022-08-11 | -$2.34 10-Q · filed 2022-08-11 | |||||
| 2021-03-31 | -$1.17 10-Q · filed 2022-05-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Nuvation Bio Inc. (NUVB) | United States | $2.007B | -13.12 |
| NEKTAR THERAPEUTICS (NKTR) | United States | $2.026B | -9.05 |
| PERRIGO Co plc (PRGO) | Ireland | $2.038B | -0.79 |
| Biohaven Ltd. (BHVN) | United States | $1.990B | -3.83 |
| Generate Biomedicines, Inc. (GENB) | United States | $2.052B | |
| AGIOS PHARMACEUTICALS, INC. (AGIO) | United States | $1.962B | -5.38 |
| Sarepta Therapeutics, Inc. (SRPT) | United States | $1.941B | -13.89 |
| Trevi Therapeutics, Inc. (TRVI) | United States | $2.091B | -51.93 |
| PALVELLA THERAPEUTICS, INC. (PVLA) | United States | $2.105B | -35.55 |
| Braveheart Bio, Inc. (BRVE) | United States | $2.106B |